Xconomy San Diego

San Diego’s Slight Rebound in Venture Investing Reflects Broader Trends—Region’s Top Deals List

Bruce V. Bigelow7/21/09Leave a Comment

(Page 2 of 2)

PhotoThera (Carlsbad, CA) — $50 million
(Investors: De Novo Ventures,Delphi Ventures, Hamilton BioVentures (FKA Hamilton Apex Technology Ventures), Individuals, Solstice Capital,TheVertical Group, Warburg Pincus.)

Intellikine (San Diego) — $28.5 million
(Investors: Abingworth Management, Biogen Idec New Ventures, CMEA Capital, Novartis Venture Fund, Sofinova Ventures, U.S. Venture Partners.)

Par Accel (San Diego and Cupertino, CA) — $22 million
(Investors: Bay Partners, Menlo Ventures, Mohr Davidow Ventures, Walden International.)

SkinMedica (Carlsbad, CA) — $9.4 million
(Investors: Domain Associates, EuclidSR Partners, Fog City Fund, HealthCare Ventures, Montreux Equity Partners.)

Medsphere Systems (Carlsbad, CA) — $6 million
(Investors: Azure Capital Partners, Epic Ventures, Thomas Weisel Venture Partners)

Nirvanix (San Diego) — $5 million
(Investors: Intel Capital, Mission Ventures, Valhalla Partners, Windward Ventures)

MojoPages (San Diego) — $4.1 million
(Investors: Austin Ventures, individual investors)

Afraxis (San Diego) — $3.3 million
(Investor: Avalon Ventures)

Loop’d Networks (San Diego) — $800,000
(Investors: Tech Coast Angels, undisclosed investors)

Bruce V. Bigelow is the editor of Xconomy San Diego. You can e-mail him at bbigelow@xconomy.com or call (619) 669-8788

Single PageCurrently on Page: 1 2 previous page

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.